KAITLYN FAKOURI: Open Payments
NPI 1821754979 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 18 payments from 10 companies in 2025. Trend: 2023 $642 · 2024 $283 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $138 |
| Exact Sciences Corporation | 3 | $65 |
| Lilly USA, LLC | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
| Mannkind Corporation | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| LNHC, Inc | 1 | $15 |
Products named: Wegovy, Rybelsus, MOUNJARO, The Cologuard Plus Collection Kit, Cologuard Collection Kit, SHINGRIX, GARDASIL 9, Kerendia.
Industry payments across CA — which companies pay providers there.
